AstronauTx
Biotech developing drugs that improve sleep architecture to treat Alzheimer's, Parkinson's and other neurological disorders.
astronautx.bio ↗Why it's here
Backed by a £48M Series A led by Novartis Venture Fund; won research funding from The Michael J. Fox Foundation and Parkinson's UK in Sep 2026.
source: astronautx.bio- Focus
- Neuroscience biotech
- Founded
- 2019
- Total raised
- £48Msource: svhealthinvestors.com
- Latest round
- Series A, £48M, Oct 2023
- London office
- Holborn Gate, 330 High Holborn, London, City of London WC1V 7QTsource: astronautx.bio
- London presence
- HQsource: astronautx.bio
- Investors
- Novartis Venture Fund (lead), Brandon Capital, Bristol Myers Squibb, Dementia Discovery Fund, EQT Life Sciences, MPM Capital, UCL Technology Fund, UK Future Fundsource: svhealthinvestors.com
- Nearest station
- Chancery Lane, 49 m
- Visas
- Licensed visa sponsor, listed as AstronauTx Limitedsource: gov.uk
- Elsewhere
- LinkedIn ↗
Verified 8 Oct 2026. How we verify · Suggest a fix
For AstronauTx
Work here? Show you're on the map. Add the badge to your site or README, or share the listing.
<a href="https://londonmempool.co.uk/c/astronautx"><img src="https://londonmempool.co.uk/badge/astronautx.svg" alt="AstronauTx is listed on London Mempool" width="357" height="28"></a>
Add ?theme=light to the image URL for light backgrounds.